| Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions (NCT00350038) | Sanofi | 2005-02-01 |
| Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy (NCT00299884) | Queen's University | 2005-01-01 |
| Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests (NCT00108212) | US Department of Veterans Affairs | 2005-01-01 |
| Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes (NCT01497912) | Karolinska Institutet | 2005-01-01 |
| Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia (NCT00487994) | Takeda | 2004-11-01 |
| Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia (NCT00330785) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-10-01 |
| Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients (NCT00357955) | Providence VA Medical Center | 2004-08-01 |
| Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers (NCT00171262) | Novartis | 2004-08-01 |
| Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction (NCT00171327) | Novartis | 2004-07-01 |
| Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (NCT00150384) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-07-01 |
| Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans (NCT00625170) | Leiden University Medical Center | 2004-05-01 |
| Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL (NCT00079638) | Kos Pharmaceuticals | 2004-04-01 |
| A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome (NCT00240305) | AstraZeneca | 2004-04-01 |
| Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes (NCT00419484) | Dokkyo Medical University | 2004-03-01 |
| Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period (NCT00845637) | Hospital de Clinicas de Porto Alegre | 2004-03-01 |
| Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels (NCT00688558) | Akros Pharma Inc. | 2004-02-01 |
| Effective Endurance Training in Metabolic Syndrome (NCT00218998) | Norwegian University of Science and Technology | 2004-01-01 |
| Intima Media Thickness Regression in Dyslipidemic Teenagers (NCT01768481) | Université de Montréal | 2004-01-01 |
| Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels (NCT00689442) | Akros Pharma Inc. | 2004-01-01 |
| A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth (NCT00069004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT) (NCT00240266) | AstraZeneca | 2003-08-01 |
| SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia (NCT00194402) | University of Washington | 2003-08-01 |
| Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care (NCT00345657) | In His Image | 2003-07-01 |
| Dyslipidemia in Type 2 Diabetes (0767-034) (NCT00547274) | Merck Sharp & Dohme LLC | 2003-07-01 |
| Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic (NCT00358033) | Providence VA Medical Center | 2003-07-01 |
| Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy (NCT00147797) | Saint Antoine University Hospital | 2003-05-01 |
| Lifestyle Intervention in Primary Health Care - the Björknäs Study (NCT00486941) | Umeå University | 2003-02-01 |
| Fenofibrate Bioequivalence Study (0767-031) (NCT00928694) | Merck Sharp & Dohme LLC | 2003-02-01 |
| Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (NCT00442325) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-01-01 |
| Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) (NCT00442845) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-01-01 |
| Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia (NCT00245388) | Bristol-Myers Squibb | 2002-04-01 |
| Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin (NCT00385931) | Novartis | 2002-01-01 |
| TTA in Treatment of Diabetes and Dyslipidemia (NCT00605787) | Haukeland University Hospital | 2002-01-01 |
| Obese Patients With Untreated Dyslipidemias (NCT00029835) | Sanofi | 2001-09-01 |
| Look AHEAD: Action for Health in Diabetes (NCT00017953) | Wake Forest University Health Sciences | 2001-06-01 |
| Regulation of Lipoprotein Metabolism in Obese Men (NCT00392717) | The University of Western Australia | 1998-02-01 |
| Effect of Abdominal Obesity on Lipoprotein Metabolism (NCT00438061) | The University of Western Australia | 1995-01-01 |
| Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins (NCT00001154) | National Heart, Lung, and Blood Institute (NHLBI) | 1976-09-03 |
| Use of Apheretic Technologies in Cardiovascular Disease (NCT02380534) | University of Pavia | |
| An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels (NCT02052986) | New York Hospital Queens | |